Hongene Biotech Corporation

Activities: Research & Development

Trending Articles

  1. Navigating AI Integration in medical device manufacturing: risks, requirements and best practices This article explores the regulatory, technical and strategic considerations associated with integrating AI into medical devices, highlighting SaMD classification, compliance...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...
  4. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding...
  5. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Hongene Biotech receives Gates Foundation grant to expand global access to mRNA vaccine raw materials

The company will use the grant to develop high-quality, affordable and patent-free cap analogues for use in mRNA vaccine production
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part II)

Industry leaders at CPHI Frankfurt are embracing emerging technologies — including automation, AI, advanced analytics and innovative manufacturing platforms — to drive efficiency, quality, scalability and sustainability in pharmaceutical production and development
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part I)

Discover how emerging technologies and expert insights are shaping the future of pharma manufacturing
Research & Development

Hongene to supply exNA oligonucleotide technology under new licensing deal

Hongene Biotech Corporation announces a non-exclusive licensing agreement with the UMass Chan Medical School to produce and supply extended nucleic acid (exNA) monomers and exNA-modified oligonucleotides for research use
Manufacturing

Pioneering LNP expert joins Hongene’s scientific advisory board

Dr Pieter Cullis to advise on RNA drug delivery and nucleic acid optimisation
Manufacturing

Hongene Biotech to manufacture Hangzhou Biotech's siRNA-based dyslipidaemia therapy

The CDMO will manufacture raw materials for the clinical development of DNV001, a novel therapy for the treatment of dyslipidaemia
Subscribe now